Allergan's board never seemed too thrilled with unsolicited $47 billion takeover proposal Valeant CEO J. Michael Pearson and partner Bill Ackman put forth last month.
written on 12.05.2014
Allergan's board never seemed too thrilled with unsolicited $47 billion takeover proposal Valeant CEO J. Michael Pearson and partner Bill Ackman put forth last month.
See our Cookie Privacy Policy Here